• , Thursday, May 20, 2004 12 AM

Recently, Senator Charles Grassley (R-IA), the Chairman of the Senate tax writing committee, introduced a bill that would allow for the reimportation of prescription drugs in the hope that it would lower drug costs for senior citizens. To get drug companies to comply with reimportation, he would take away the tax deduction of advertising expenses from any company that took action to impede reimportation. Companies that do not take actions to impede reimportation would get a tax credit on research and development (R & D) expenses.

Read the whole story at »